Insmed Inc (STU:IM8N)
€ 67 0.5 (0.75%) Market Cap: 11.95 Bil Enterprise Value: 11.50 Bil PE Ratio: 0 PB Ratio: 25.75 GF Score: 63/100

Insmed Inc at Credit Suisse Healthcare Conference Transcript

Nov 08, 2022 / 07:35PM GMT
Release Date Price: €18.1 (-0.55%)
Judah C. Frommer;dit Suisse AG
CrÃ;Research Division - Senior Analyst

© -

Hi, everyone. I'm Judah Frommer. I cover smid-cap biotech here at Credit Suisse, and we're thrilled to have Will Lewis, Chair and CEO of Insmed here with us for this session. So well, maybe we'll just start out with a quick intro on the company. You've outlined the framework of 4 strategic pillars.

Questions & Answers

Judah C. Frommer;dit Suisse AG
CrÃ;Research Division - Senior Analyst

© -

And to better understand the Insmed story, can you walk us through those pillars and where the organizational and economic leverage is between them?

William H. Lewis
Insmed Incorporated - President, CEO & Chairman

Yes, sure. So I have to say this is our first conference since we've completed our recent financing, and it is a particularly exciting time at the company because entered that financing and probably the strongest position the company has ever been in since I joined 10 years ago. We

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot